Cargando…

Serum Galectin-3 Levels in Children with Attention-Deficit/Hyperactivity Disorder

OBJECTIVE: Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with underlying pathogenesis and etiological factors not fully understood. We assumed that galectin-3, which is also linked with inflammatory responses, may play an important role in the ethiopathogenesis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Işık, Ümit, Kılıç, Faruk, Demirdaş, Arif, Aktepe, Evrim, Aydoğan Avşar, Pınar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113172/ https://www.ncbi.nlm.nih.gov/pubmed/32151128 http://dx.doi.org/10.30773/pi.2019.0247

Ejemplares similares

The Relationship between Second-to-Fourth Digit Ratios, Attention-Deficit/Hyperactivity Disorder Symptoms, Aggression, and Intelligence Levels in Boys with Attention-Deficit/Hyperactivity Disorder
por: Işık, Ümit, et al.
Publicado: (2020)

Serum galectin-3 levels are decreased in schizophrenia
por: Kiliç, Faruk, et al.
Publicado: (2020)

Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia
por: Kiliç, Faruk, et al.
Publicado: (2020)

Evaluation of Anxiety Sensitivity, Anxiety, Depression, and Attention Deficit Hyperactivity Disorder in Patients with Tinnitus
por: Kumbul, Yusuf Çağdaş, et al.
Publicado: (2022)

Investigation of second to fourth finger length ratio (2D:4D) in patients with bipolar disorder
por: Kɪlɪç, Faruk, et al.
Publicado: (2020)

Serum TSH Levels are Associated with Hyperactivity Behaviors in Children with Attention Deficit/Hyperactivity Disorder
por: Chen, Guanru, et al.
Publicado: (2023)

The study of Tau and phospho Tau protein levels in attention deficit and hyperactivity disorder
por: SARAÇOĞLU, Hatice, et al.
Publicado: (2021)

Serum ferritin levels in children with attention deficit hyperactivity disorder and tic disorder
por: Tang, Cai-Yun, et al.
Publicado: (2022)

Presentation and outcomes of attention deficit and hyperactivity disorder in females and males
por: Kilic, O., et al.
Publicado: (2021)

The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder
por: SHARIF, Mohammad Reza, et al.
Publicado: (2015)

Increased Serum Hepcidin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Yazici, Kemal Utku, et al.
Publicado: (2019)

Determination of Serum Vascular Endothelial Growth Factor Levels in Attention Deficit Hyperactivity Disorder: A Case Control Study
por: Torun, Yasemin Taş, et al.
Publicado: (2019)

Low serum sphingolipids in children with attention deficit-hyperactivity disorder
por: Henríquez-Henríquez, Marcela P., et al.
Publicado: (2015)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Neuroimaging in attention-deficit/hyperactivity disorder
por: Pereira-Sanchez, Victor, et al.
Publicado: (2021)

Attention-deficit/hyperactive disorder updates
por: Kessi, Miriam, et al.
Publicado: (2022)

Anxiety and Somatic Symptoms in Children and Adolescents Diagnosed with Attention-Deficit Hyperactivity Disorder
por: Okyar, Esra, et al.
Publicado: (2023)

Alterations in the Glycan Composition of Serum Glycoproteins in Attention-Deficit Hyperactivity Disorder
por: Kianičková, Kristína, et al.
Publicado: (2023)

Examining the autistic traits in children and adolescents diagnosed with attention-deficit hyperactivity disorder and their parents
por: Okyar, Esra, et al.
Publicado: (2020)

The Effectiveness of Methylphenidate in the Treatment of Encopresis Independent from Attention-Deficit Hyperactivity Disorder Symptoms
por: Akça, Ömer Faruk, et al.
Publicado: (2015)

Assessment of intraocular pressure, macular thickness, retinal nerve fiber layer, and ganglion cell layer thicknesses: ocular parameters and optical coherence tomography findings in attention-deficit/hyperactivity disorder
por: Işik, Ümit, et al.
Publicado: (2020)

Attention deficit hyperactivity disorder (ADHD) & COVID-19: Attention deficit hyperactivity disorder: Consequences of the 1st wave
por: Insa, I., et al.
Publicado: (2021)

A Different View on the Etiopathogenesis of Attention-deficit Hyperactivity Disorder from an Inflammation Perspective
por: Dursun, Semiha, et al.
Publicado: (2021)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Animal models of attention-deficit hyperactivity disorder
por: Russell, Vivienne A, et al.
Publicado: (2005)

Attention Deficit Hyperactivity Disorder in Epileptic Children
por: Kim, Gun-Ha, et al.
Publicado: (2012)

Attention-deficit/hyperactivity disorder in postsecondary students
por: Nugent, Kevin, et al.
Publicado: (2014)

What causes attention deficit hyperactivity disorder?
por: Thapar, Anita, et al.
Publicado: (2012)

Interoceptive awareness in attention deficit hyperactivity disorder
por: Wiersema, Jan R., et al.
Publicado: (2018)

Chiari Malformation and Attention Deficit Hyperactivity Disorder
por: DuBow, Anaïs, et al.
Publicado: (2020)

AOD Use and Attention Deficit/Hyperactivity Disorder
por: Wilens, Timothy E.
Publicado: (1998)

Localization and Diagnosis of Attention-Deficit/Hyperactivity Disorder
por: Wang, Peng, et al.
Publicado: (2021)

Yoga for the Management of Attention-Deficit/Hyperactivity Disorder
por: Gunaseelan, Luxhman, et al.
Publicado: (2021)

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jt5ofie3jdqe18cn6s3krmsn98